Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1983 1
1984 1
1986 1
1989 1
1992 2
1993 1
1994 2
1995 5
1996 5
1997 6
1998 10
1999 6
2000 9
2001 13
2002 12
2003 9
2004 14
2005 4
2006 17
2007 16
2008 11
2009 17
2010 16
2011 24
2012 21
2013 15
2014 13
2015 23
2016 28
2017 40
2018 30
2019 21
2020 31
2021 32
2022 42
2023 35
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

478 results

Results by year

Filters applied: . Clear all
Page 1
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group. Galiè N, et al. Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. Eur Heart J. 2016. PMID: 26320113 Free article. No abstract available.
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Konstantinides SV, et al. Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k. doi: 10.1093/eurheartj/ehu283. Epub 2014 Aug 29. Eur Heart J. 2014. PMID: 25173341 Free article. No abstract available.
Prévention des risques liés à un usage inapproprié/consommation inutile des médicaments.
Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V. Cracowski JL, et al. Among authors: micallef j. Therapie. 2022 Jan-Feb;77(1):69-78. doi: 10.1016/j.therap.2021.12.020. Epub 2022 Jan 4. Therapie. 2022. PMID: 35067334 Free PMC article. French.
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Pariente A, Micallef J, Lahouegue A, Molimard M, Auffret M, Chouchana L, Denis B, Faillie JL, Grandvuillemin A, Letinier L, Pierron E, Pons C, Pujade I, Rubino H, Salvo F. Pariente A, et al. Among authors: micallef j. Therapie. 2023 Jan-Feb;78(1):115-129. doi: 10.1016/j.therap.2022.11.003. Epub 2022 Nov 25. Therapie. 2023. PMID: 36577617 French. No abstract available.
Quelles actions pour lutter contre la désinformation sur les produits de santé ?
Micallef J, Maisonneuve H, Muller S, Molimard M, Bégaud B, Cabut S, Daban M, Drici MD, Gatignol C, Grumblat A, Guaspare-Cartron C, Lasserre B, Mebarki A, Pons C, Prabonnaud F, Raynaud C, Saint-Lary O. Micallef J, et al. Therapie. 2024 Jan-Feb;79(1):75-86. doi: 10.1016/j.therap.2023.10.004. Epub 2023 Oct 29. Therapie. 2024. PMID: 37985308 French. No abstract available.
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: micallef j. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
Propofol and infectious complications.
Micallef J, Pietri T. Micallef J, et al. Therapie. 2023 Jul-Aug;78(4):349-351. doi: 10.1016/j.therap.2022.10.007. Epub 2022 Oct 17. Therapie. 2023. PMID: 37105896 No abstract available.
478 results